Alejandro Balsa focuses on Rheumatoid arthritis, Immunology, Internal medicine, Arthritis and Allele. His Rheumatoid arthritis research is multidisciplinary, relying on both Endocrinology, Connective tissue disease, Physical therapy and CXCR5. The various areas that Alejandro Balsa examines in his Immunology study include Odds ratio, PTPN22, Genetic association and Genotype.
The Internal medicine study combines topics in areas such as Gastroenterology and Surgery. His Surgery research incorporates themes from Severity of illness, Incidence, Cohort study and Cohort. Alejandro Balsa combines subjects such as Psoriasis, Synovial fluid, Randomized controlled trial, Lupus erythematosus and Placebo with his study of Arthritis.
His primary scientific interests are in Internal medicine, Rheumatoid arthritis, Immunology, Gastroenterology and Arthritis. His research investigates the connection with Internal medicine and areas like Surgery which intersect with concerns in Adverse effect. Alejandro Balsa interconnects Antibody, Disease and Methotrexate in the investigation of issues within Rheumatoid arthritis.
His study on Immunology also encompasses disciplines like
Alejandro Balsa mainly focuses on Internal medicine, Rheumatoid arthritis, In patient, Rheumatology and Psoriatic arthritis. Internal medicine is closely attributed to Gastroenterology in his research. His biological study focuses on Rheumatoid factor.
His Rheumatology research is multidisciplinary, relying on both Vedolizumab, Inflammatory bowel disease, Ulcerative colitis, Orthopedic surgery and Rheumatism. Alejandro Balsa usually deals with Psoriatic arthritis and limits it to topics linked to BASDAI and Prospective cohort study. His Autoantibody research is included under the broader classification of Immunology.
The scientist’s investigation covers issues in Rheumatoid arthritis, Internal medicine, Rheumatology, Psoriatic arthritis and Intensive care medicine. His Rheumatoid arthritis research is under the purview of Immunology. He combines subjects such as Gastroenterology and Endocrinology with his study of Internal medicine.
His biological study deals with issues like Methotrexate, which deal with fields such as Drug and Rheumatism. His work on Secukinumab and Nail psoriasis is typically connected to In patient as part of general Psoriatic arthritis study, connecting several disciplines of science. Alejandro Balsa has included themes like Treatment outcome, Medical prescription, Biosimilar and Drug Substitution in his Intensive care medicine study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
Maxime Dougados;Martin Soubrier;Anna Antunez;Peter Balint.
Annals of the Rheumatic Diseases (2013)
New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study
François Cornélis;Sabine Fauré;Maria Martinez;Jean-François Prud’homme.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
Gisela Orozco;Elena Sánchez;Miguel A González-Gay;Miguel A López-Nevot.
Arthritis & Rheumatism (2005)
Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis
Dora Pascual-Salcedo;Chamaida Plasencia;Susana Ramiro;Laura Nuño.
Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity
L Carmona;I González-Alvaro;A Balsa;M Angel Belmonte.
Annals of the Rheumatic Diseases (2003)
Increased risk of tuberculosis in patients with rheumatoid arthritis.
Loreto Carmona;César Hernández-García;Cristina Vadillo;Esperanza Pato.
The Journal of Rheumatology (2003)
Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review
Vibeke Strand;Alejandro Balsa;Jamal Al-Saleh;Leonor Barile-Fabris.
Association of rheumatoid arthritis with a functional chemokine receptor, CCR5.
J. J. Gomez-Reino;J. L. Pablos;P. E. Carreira;B. Santiago.
Arthritis & Rheumatism (1999)
IL-15 and the Initiation of Cell Contact-Dependent Synovial Fibroblast-T Lymphocyte Cross-Talk in Rheumatoid Arthritis: Effect of Methotrexate
María-Eugenia Miranda-Carús;Alejandro Balsa;Marta Benito-Miguel;Carlos Pérez de Ayala.
Journal of Immunology (2004)
Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.
Alejandro Balsa;Loreto Carmona;Isidoro González-Alvaro;Miguel Angel Belmonte.
The Journal of Rheumatology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: